LCCC 1027: Expression Of P16INK4a As A Predictor Of Myelosuppression In Patients With Breast Cancer
Observational Model: Case-Only, Time Perspective: Prospective
Determine if p16INK4a Expression at Baseline is Related to Nadir Neutrophil Counts in Women with Breast Cancer Receiving Chemotherapy
To measure and correlate baseline p16INK4a expression in subjects with stage I-IV breast cancer starting a new course of chemotherapy with a post cycle 1 chemotherapy absolute neutrophil count (ANC).
Hyman Muss, MD
University of North Carolina
United States: Institutional Review Board
|University of North Carolina||Chapel Hill, North Carolina 27599|